Single-shot spinal anesthesia for cesarean delivery — dosing, dermatomal spread, and hemodynamic management
Safe spinal anesthesia for cesarean delivery begins before the needle ever touches skin. Correct positioning maximizes interspinous gap, protects the spinal cord, and sets up the physics that will govern drug spread in the next stage.
Two positions are used routinely for obstetric spinal anesthesia:
• Sitting position: the patient sits on the edge of the bed, feet supported, back flexed into a "C" shape ("angry cat" or "mad cat" posture), arms resting on a pillow or an assistant's shoulders. This position often makes midline landmarks easier to palpate in patients with a high BMI and allows gravity-assisted identification of the midline.
• Lateral decubitus position: the patient lies on her side with knees drawn to chest and neck flexed. This position is preferred when the fetal heart rate is non-reassuring, when a support person needs to remain present, or when maternal sedation risk is higher — it avoids the vasovagal risk of prolonged sitting.
Both positions achieve the same goal: maximal flexion widens the interlaminar and interspinous spaces by several millimeters, easing needle passage through the ligamentum flavum.
Tuffier's line (also called the intercristal line) is an imaginary line connecting the top of both iliac crests. In most adults it crosses the vertebral column at the L4 spinous process or the L4–L5 interspace, making it the single most useful landmark for level identification.
Using this line, the L3–L4 or L4–L5 interspace is selected for needle insertion. This choice is deliberate: the spinal cord (conus medullaris) typically terminates at the L1–L2 level in adults, but can extend as low as L2–L3 in a small percentage of patients. Inserting at or below L3–L4 provides a wide safety margin against direct needle trauma to neural tissue.
Ultrasound-assisted landmark identification is increasingly used in patients with a high BMI, scoliosis, or previous spine surgery, where palpation alone is unreliable — studies show ultrasound reduces the number of needle passes and insertion attempts.
Never insert above L2–L3 for a routine spinal — clinical studies using MRI/cadaveric mapping show anesthesiologists frequently misjudge the interspace one to two levels higher than intended when relying on palpation alone, which is why staying at or below L3–L4 is the standard safety buffer.
From 20 weeks' gestation onward, the gravid uterus can compress the inferior vena cava and aorta when the mother lies supine, reducing venous return and cardiac output by up to 30% — "supine hypotension syndrome." This is compounded by the sympathetic blockade that spinal anesthesia is about to produce.
Standard practice is 15° left uterine displacement, achieved with a wedge under the right hip or by manually tilting the operating table, maintained continuously from the moment the patient lies supine until delivery. This single maneuver meaningfully improves venous return, cardiac output, and uteroplacental perfusion, and is applied in every stage that follows in this simulation via the Table Tilt control.
The spinal needle must traverse five anatomical layers before reaching the subarachnoid space. Free-flowing cerebrospinal fluid at the needle hub is the definitive, non-negotiable confirmation of correct placement before any drug is injected.
From skin to subarachnoid space, the needle passes through: skin → subcutaneous fat → supraspinous ligament → interspinous ligament → ligamentum flavum → epidural space (a potential space containing fat and veins) → dura mater → arachnoid mater → subarachnoid space (containing CSF and the cauda equina).
A pencil-point needle (Whitacre or Sprotte design) with a side-facing aperture is preferred over a cutting-tip (Quincke) needle. Because it spreads dural fibers apart rather than cutting them, it dramatically lowers the risk of post-dural puncture headache (PDPH) — a major source of maternal morbidity after obstetric neuraxial anesthesia.
A distinct "give" or loss of resistance is often felt as the needle passes through the ligamentum flavum and again through the dura — the second, more subtle click signals subarachnoid entry. An introducer needle is typically used first to guide the thin spinal needle and prevent it from bending.
Once the stylet is withdrawn, free, gravity-driven flow of clear CSF from the needle hub is the essential confirmation step. If flow is absent or sluggish, the needle may be gently rotated 90° (the aperture may be pressed against a nerve root or the dura) before any further advancement is considered.
Blood-tinged CSF that does not clear suggests a traumatic tap and warrants reassessment; frankly bloody return that fails to clear may require choosing a different interspace. CSF should never be forced or aspirated aggressively — this can traumatize the cauda equina.
Once free flow is confirmed, the syringe containing the local anesthetic is firmly attached to the needle hub without moving the needle tip, and a gentle aspiration test (drawing back a small amount of CSF to see it swirl and clear in the syringe, then reinjecting) reconfirms placement immediately before the full dose is given.
CSF flow is the only acceptable confirmation of subarachnoid needle placement — unlike epidural anesthesia, there is no "loss of resistance to air/saline" step for a spinal, because the target space itself is defined by the presence of fluid.
A skin wheal of 1% lidocaine (2–3 mL) is infiltrated at the insertion site and along the anticipated needle tract before the spinal needle is passed, minimizing the discomfort of the introducer needle.
Strict aseptic technique — hand hygiene, sterile gloves, chlorhexidine skin preparation allowed to fully dry, and a fenestrated sterile drape — is mandatory; iatrogenic meningitis, while rare, is a devastating and largely preventable complication.
Paresthesia (a sudden shooting sensation down a leg) during needle advancement indicates contact with a nerve root of the cauda equina; the needle should be withdrawn slightly and redirected, not advanced further, and the patient should be warned in advance that a brief, transient sensation is possible and not dangerous if the needle is immediately repositioned.
Baricity — the density of the local anesthetic solution relative to CSF — is the single most powerful, clinician-controllable variable determining how high a spinal block will spread. Hyperbaric bupivacaine, made denser than CSF with added dextrose, obeys gravity for roughly the first 15–20 minutes after injection.
A typical intrathecal dose of 0.5% hyperbaric bupivacaine for cesarean delivery is 8–12 mg (1.6–2.4 mL), most commonly combined with an intrathecal opioid to improve block quality and prolong postoperative analgesia without adding local anesthetic:
• Fentanyl 10–25 mcg — fast-onset intraoperative visceral analgesia • Morphine 100–200 mcg (preservative-free) — 12–24 hours of postoperative analgesia, the mainstay of multimodal post-cesarean pain control
Dose is chosen based on patient height, anticipated surgical duration, and institutional protocol; taller patients and longer anticipated procedures generally receive doses toward the upper end of the range. Under-dosing risks an inadequate block; over-dosing raises the risk of an excessively high block and more pronounced hypotension.
CSF has a specific gravity of approximately 1.003–1.010 at 37°C. Bupivacaine is manufactured as a hyperbaric solution by adding 8% dextrose, raising its specific gravity to roughly 1.020–1.030 — meaningfully denser than CSF.
Once injected into the subarachnoid space, a hyperbaric solution behaves like a dense fluid layer that flows to the most dependent (lowest) point of the CSF column, following the natural curves of the spine (the lumbar lordosis and thoracic kyphosis) and, critically, the tilt of the operating table.
This is fundamentally different from isobaric bupivacaine (same density as CSF, spreads more predictably but less influenced by position — useful for lower-limb or perineal surgery) and hypobaric solutions (less dense than CSF, float upward — used mainly in specific orthopedic positioning scenarios, rarely in obstetrics).
Because hyperbaric solution sinks toward the lowest point in the CSF column, head-down (Trendelenburg) tilt after injection drives the block cephalad toward the thoracic and cervical dermatomes, while head-up (reverse Trendelenburg) tilt restrains it caudally — this is precisely what the Table Tilt slider models in this simulation.
Spread is not instantaneous, nor is it permanent. Over the first 5–10 minutes, the drug diffuses and mixes within the CSF while gravity continues to act on the denser hyperbaric layer; by 15–20 minutes, a substantial fraction of the local anesthetic has bound to neural tissue and lipid membranes, and further repositioning has progressively less effect ("fixation").
This creates a genuine clinical window: immediately after injection, the anesthesiologist can actively titrate final block height using head-up or head-down tilt, before helping the patient to a slight left-tilted supine position for surgery. Waiting too long to reposition, or repositioning too aggressively, are both recognized causes of unpredictable block height.
Other modifiable factors affecting spread include injected volume, injection speed, patient height, and lumbar CSF volume (which is inversely related to BMI and intra-abdominal pressure — higher intra-abdominal pressure in term pregnancy modestly reduces CSF volume and can increase spread for a given dose).
Before the first incision, the anesthesia team must objectively confirm the block is both high enough and dense enough for surgery. Testing methodically from a known-blocked area upward, using two different sensory modalities, is the standard of care.
A block reaching T6 (xiphoid process) is generally sufficient for a pain-free skin and fascial incision. However, cesarean delivery also involves handling and exteriorizing the uterus, which is innervated by visceral afferents that travel with the sympathetic chain up to T4 and even T2–T3.
Peritoneal traction, uterine exteriorization, and traction on the round ligaments and fallopian tubes can cause significant visceral discomfort, nausea, and referred shoulder-tip pain even with a "surgically adequate" T6 skin block. For this reason, the accepted target sensory level for cesarean delivery is T4 (nipple line), which reliably blunts this visceral component.
Some protocols cite a range of T4 to T6 as acceptable depending on surgical technique and patient tolerance, but T4 remains the widely taught target that best predicts intraoperative comfort.
Two sensory modalities are tested, moving systematically from a caudal (already-blocked, e.g. sacral) region cephalad toward the clavicles, comparing each dermatome to an unblocked reference area (such as the face or upper chest):
• Cold sensation (ice cube or alcohol swab): tests A-delta fiber-mediated cold/temperature sensation, which is blocked first and at the lowest local anesthetic concentration. Loss of cold sensation correlates closely with sympathetic blockade and is a fast, simple bedside screen.
• Pinprick (blunted needle or neuro-tip): tests A-delta pain fiber transmission, blocked at a slightly higher local anesthetic concentration than cold. Loss of sharp pinprick sensation correlates most closely with adequate surgical anesthesia and is generally considered the more clinically predictive test before incision.
Assessment is repeated at approximately 2-minute intervals, mapping the rising level, until it plateaus — typically 10–15 minutes after injection, sometimes up to 20 minutes.
Because differential blockade means sympathetic fibers are blocked roughly 2 dermatomal segments higher than cold sensation, and cold sensation is lost roughly 2 segments higher than pinprick/surgical anesthesia, a "T4 to cold" reading typically corresponds to a true surgical (pinprick) level closer to T6 — this gap is why many protocols wait for cold testing to reach T2–T3 before declaring the block ready.
If the block plateaus below T6, or is patchy/asymmetric, options include: repositioning and allowing more time (if still within the positional window), supplementing with local infiltration or intravenous analgesia for a marginal deficit, or — for a clearly inadequate block — repeating the spinal at a different interspace with a reduced dose (with caution, since an unrecognized partial block plus a full repeat dose can summate to a dangerously high block), placing an epidural for slow, titratable top-up, or converting to general anesthesia if surgery cannot be safely delayed (e.g., category 1 emergency) or the deficit is severe.
A motor block assessment (modified Bromage scale, grading hip/knee/ankle movement) is also performed and, together with the sensory level, forms the complete picture of block adequacy documented before surgery begins.
Spinal anesthesia blocks sympathetic outflow before it blocks sensation, producing widespread vasodilation below the block level. In the pregnant patient, this hypotension threatens both maternal well-being and placental perfusion — and demands prompt, protocolized vasopressor treatment.
Sympathetic preganglionic fibers are thin, unmyelinated or lightly myelinated B-fibers that are blocked by local anesthetic at a lower concentration — and therefore over a wider dermatomal range — than the sensory (A-delta) or motor (A-alpha) fibers. The sympathetic block level typically extends 2 segments higher than the measured sensory level.
For a T4 sensory block, sympathetic blockade may extend to roughly T2 or higher, denervating a large territory of splanchnic and peripheral vasculature. The result is arterial and venous vasodilation, reduced systemic vascular resistance, reduced venous return, and consequently a fall in cardiac output and blood pressure — occurring in an estimated 70–80% of obstetric spinal patients if no prophylaxis is given.
In the parturient, this is compounded by aortocaval compression from the gravid uterus (mitigated by left uterine displacement) and by the fact that uteroplacental perfusion has no autoregulation — it is directly dependent on maternal perfusion pressure, so maternal hypotension can rapidly translate into reduced fetal oxygen delivery and fetal acidosis.
Phenylephrine, a pure alpha-1 adrenergic agonist, is now the first-line vasopressor for spinal-induced hypotension in obstetric anesthesia. It restores blood pressure primarily through arterial vasoconstriction with minimal direct effect on the uterine vasculature at clinical doses, and multiple trials show it is associated with less fetal acidosis than ephedrine.
Typical dosing: intermittent IV boluses of 50–100 mcg as needed, or a prophylactic/therapeutic infusion of 25–50 mcg/min (some protocols use up to 100 mcg/min) titrated to maintain systolic blood pressure at or above 90% of the pre-spinal baseline. Because phenylephrine is a pure vasoconstrictor, it can provoke a reflex bradycardia — heart rate should be monitored, and a small dose of atropine or a temporary reduction in phenylephrine is used if bradycardia becomes significant.
Fluid co-loading with 10–15 mL/kg of crystalloid, given rapidly at or just before the time of spinal injection (rather than "preloading" well beforehand, which has limited benefit and is now largely abandoned), is used alongside — not instead of — vasopressor therapy.
Current obstetric anesthesia consensus favors treating spinal hypotension proactively with a prophylactic phenylephrine infusion started at the time of spinal injection, rather than waiting reactively for blood pressure to fall — proactive strategies produce more stable maternal hemodynamics and less nausea/vomiting.
Ephedrine (an indirect and direct-acting agonist with both alpha and beta effects) remains useful when hypotension is accompanied by significant bradycardia, since its beta-1 activity increases heart rate and cardiac output alongside vasoconstriction. Typical dosing is 5–10 mg IV bolus, titrated. Ephedrine crosses the placenta more readily than phenylephrine and historically was associated with greater fetal metabolic acidosis, though the clinical significance of this in a well-monitored setting is debated.
Norepinephrine, with both alpha-agonist (vasoconstrictor) and modest beta-agonist activity, has emerged in recent evidence as an effective alternative to phenylephrine that better preserves heart rate and cardiac output, typically dosed as an infusion (e.g., 0.025–0.1 mcg/kg/min or fixed-rate protocols) with growing but not yet universal adoption in obstetric units.
Regardless of agent chosen, the goal is the same: maintain maternal systolic blood pressure close to baseline throughout the case, since even brief, severe hypotension can cause maternal nausea/vomiting, altered consciousness, and reduced placental perfusion.
| Product | Indication | Trial Design | Key Result |
|---|---|---|---|
| Phenylephrine | Pure α1-agonist | Bolus 50–100 mcg IV or infusion 25–50 mcg/min, titrated to SBP ≥90% baseline | First-line; least fetal acidosis; may cause reflex bradycardia |
| Ephedrine | Mixed α/β-agonist | Bolus 5–10 mg IV, repeated as needed | Preferred with bradycardia; increases HR and cardiac output |
| Norepinephrine | α-agonist with mild β activity | Low-dose infusion, fixed-rate or weight-based protocols | Preserves heart rate/cardiac output better than phenylephrine alone |
| Crystalloid co-load | Volume expansion | 10–15 mL/kg rapid IV bolus given at time of spinal injection | Adjunct only — does not replace vasopressor therapy |
A spinal block is a moving target with a narrow therapeutic window. Too low, and the mother experiences surgical pain; too high, and she can lose the ability to breathe. Recognizing both failure patterns early is essential to safe obstetric anesthesia practice.
If local anesthetic spreads unintentionally to the cervical spinal cord and brainstem, the results can be catastrophic. The diaphragm is innervated by the phrenic nerve, arising from cervical roots C3, C4, and C5 ("C3, 4, 5 keep the diaphragm alive"). Blockade at this level causes progressive diaphragmatic weakness and, at its extreme, complete apnea.
Warning signs develop in sequence as the block ascends: hand/arm weakness or tingling, difficulty phonating or a hoarse/weak voice, dyspnea or a sense of chest heaviness, nausea from unopposed vagal tone and severe hypotension, then bradycardia progressing to bradyarrhythmia, and finally loss of consciousness with apnea if the block reaches the brainstem and blocks cranial nerve/reticular activating system function alongside profound hypotension-induced cerebral hypoperfusion.
Risk factors include excessive dose, unintended intrathecal (rather than epidural) injection of a dose intended for the epidural space, aggressive head-down positioning immediately after a hyperbaric injection, and small patient stature.
Total spinal is a true anesthetic emergency: management is immediate airway support (bag-mask ventilation, then intubation if apnea persists), aggressive vasopressor and fluid therapy to support blood pressure, continued left uterine displacement, and expedited delivery of the baby if maternal instability does not rapidly resolve — full recovery is expected as the block regresses over 1–2 hours provided oxygenation and circulation are maintained throughout.
A block that plateaus below T6, or one that is asymmetric or patchy ("missed segments"), leaves the patient with pain during incision, peritoneal entry, or uterine exteriorization even though some sensory loss is present. Reported rates of clinically significant intraoperative discomfort vary widely (roughly 1–17%) depending on how strictly "inadequate" is defined.
Common causes include: too low a dose for the patient's height or the anticipated case duration, loss of positional control before adequate spread occurred, anatomical variants (e.g., unrecognized spinal deformity or prior instrumentation), and simply testing and proceeding to incision too early, before the block has reached its true plateau.
Management escalates with severity: reassurance and additional time if the deficit is trivial and the level is only marginally low; local infiltration or intravenous adjuncts (e.g., low-dose ketamine, nitrous oxide) for a mild-to-moderate deficit; and prompt conversion to general anesthesia for significant, uncontrolled pain — especially once the baby is delivered and rapid, definitive pain control becomes the priority.
These two failure modes sit at opposite ends of the same dose–position–baricity relationship explored in Stage 3 of this simulation: higher doses and more head-down tilt push the block higher (risking total spinal), while lower doses and head-up tilt keep it lower (risking inadequate anesthesia).
The clinical target — T4, achieved with a carefully chosen 8–12 mg dose, brief and controlled positional adjustment, then a return to a slight left tilt for surgery — is a deliberately conservative compromise that keeps the vast majority of patients comfortably within the safe zone between these two failure modes.
Continuous vigilance after injection — verbal contact with the patient, monitoring voice quality and hand strength, continuous pulse oximetry, frequent blood pressure measurement, and a clear escalation plan — is what allows a rare total spinal to be caught and treated within seconds rather than minutes, and what allows an inadequate block to be recognized and corrected before the first incision rather than mid-surgery.